Cancer treatment combination therapy comprising vinflunine and trastuzumab

Details for Australian Patent Application No. 2008257555 (hide)

Owner Pierre Fabre Medicament F.Hoffman-La Roche Ltd

Inventors Delgado, Francois-Michel; Pinel, MarieClaire; Vanhauwere, Bart

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008257555

PCT Pub. Number WO2008/145697

Priority 07290679.5 31.05.07 EP

Filing date 29 May 2008

Wipo publication date 4 December 2008

International Classifications

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

A61K 31/4745 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

14 January 2010 PCT application entered the National Phase

  PCT publication WO2008/145697 Priority application(s): WO2008/145697

14 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008257559-Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (MGLU2 receptor)

2008257541-Method and apparatus for operation of a marine vessel hybrid propulsion system